Enantioselective synthesis of saframycin A and evaluation of antitumor activity relative to ecteinascidin/saframycin hybrids

Organic Letters

Volumn 1, Issue 1, 1999, Pages 75-77

  Martinez, Eduardo J ^a   Corey, E J ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIOXOLANE DERIVATIVE; ALKYLATING AGENT; ANTINEOPLASTIC ANTIBIOTIC; ISOQUINOLINE DERIVATIVE; SAFRAMYCIN A; TETRAHYDROISOQUINOLINE DERIVATIVE; TRABECTEDIN;

ARTICLE; CELL CULTURE; CHEMISTRY; DRUG SCREENING; HUMAN; STEREOISOMERISM; SYNTHESIS;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; DIOXOLES; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; ISOQUINOLINES; STEREOISOMERISM; TETRAHYDROISOQUINOLINES; TUMOR CELLS, CULTURED;

EID: 0033565004     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol990553i     Document Type: Article

References (21)

1. (a) Rinehart, K. L.; Holt, T. G.; Fregeau, N. L.; Keifer, P. A.; Wilson, G. R.; Perun, T. J., Jr.; Sakai, R.; Thompson, A. G.; Stroh, J. G.; Shield, L. S.; Seigler, D. S.; Li, L. H.; Martin, D. G.; Grimmelikhuijzen, C. J. P.; Gäde, G. J. Nat. Prod. 1990, 53, 771.
2. (b) Rinehart, K. L.; Sakai, R.; Holt, T. G.; Fregeau, N. L.; Perun, T. J., Jr.; Seigler, D. S.; Wilson, G. R.; Shield, L. S. Pure Appl. Chem. 1990, 62, 1277.
3. (c) Rinehart, K. L.; Holt, T. G.; Fregeau, N. L.; Stroh, J. G.; Keifer, P. A.; Sun, F.; Li, L. H.; Martin, D. G. J. Org. Chem. 1990, 55, 4512.
4. (d) Wright, A. E.; Forleo, D. A.; Gunawardana, P. G.; Gunasekera, S. P.; Koehn, F. E.; McConnell, O. J. J. Org. Chem. 1990, 55, 4508.
5. (e) Sakai, R.; Rinehart, K. L.; Guan, Y.; Wang, A. H.-J. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 11456.
6. (f) Sakai, R.; Jares-Erijman, E. A.; Manzanares, I.; Elipe, M. V. S.; Rinehart, K. L. J. Am. Chem. Soc. 1996, 118, 9017.
7. Corey, E. J.; Gin, D. Y.; Kania, R. S. J. Am. Chem. Soc. 1996, 118, 9202.
8. (a) Arai, T.; Takahashi, K.; Kubo, A. J. Antibiot. 1977, 30, 1015.
9. (b) Arai, T.; Takahashi, K.; Nakahara, S.; Kubo, A. Experientia 1980, 36, 1025.
10. For reviews on the saframycins, see: (a) Arai, T.; Kubo, A. In The Alkaloids Chemistry and Pharmacology;. Brossi, A., Ed.; Academic Press: New York, 1983; Vol. 21, Chapter 3.
11. (b) Remers, W. A. In The Chemistry of Antitumor Antibiotics; Wiley: New York, 1988: Vol. 2, Chapter 3.
12. (a) Fukuyama, T.; Yang, L.; Ajeck, K. L.; Sachleben, R. A. J. Am. Chem. Soc. 1990, 112, 3712.
13. (b) Myers, A. G.; Kung, D. Book of Abstracts, 216th National Meeting of the American Chemical Society, Boston, MA: American Chemical Society, Washington, DC, 1998; Abstract ORGN0501.
14. (a) Staros, J. V.; Bayley, H.; Standring, D. N.; Knowles, J. R. Biochem. Biophysic. Res. Commun. 1978, 80, 568.
15. (b) Bayley, H.; Standring, D. N.; Knowles, J. R. Tetrahedron Lett. 1978, 39, 3633.
16. Hydrogen sulfide in pyridine was less effective for the azide → amine reduction, see: Adachi, T.; Yamada, Y.; Inoue, I. Synthesis 1977, 45.
17. (a) Umemoto, T.; Kawada, K.; Tomita, K. Tetrahedron Lett. 1986, 27, 4465.
18. (b) Umemoto, T.; Fukami, S.; Tomizawa, G.; Harasawa, K.; Kawada, K.; Tomita, K. J. Am. Chem. Soc. 1990, 112, 8563.
19. (c) Lal, G. S.; Pez, G. P.; Syvret, R. G. Chem. Rev. 1996, 96, 1737.
20. De Jonge, C. R. H. I.; Hageman, H. J.; Hoentjen, G.; Mus, W. J. Organic Syntheses; Wiley: New York, 1988; Collect Vol. VI, p 412.
21. Martinez, E. J.; Owa, T.; Schreiber, S. L.; Corey, E. J. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 3496.